Peak Pharmaceuticals (OTCMKTS:PKPH) Shares Down 0.6% – What’s Next?

Shares of Peak Pharmaceuticals, Inc. (OTCMKTS:PKPHGet Free Report) were down 0.6% during mid-day trading on Thursday . The company traded as low as $0.9811 and last traded at $0.9943. 10,070 shares traded hands during mid-day trading, an increase of 11% from the average session volume of 9,053 shares. The stock had previously closed at $1.00.

Peak Pharmaceuticals Price Performance

The firm has a 50-day moving average of $0.97 and a 200 day moving average of $1.24.

Peak Pharmaceuticals Company Profile

(Get Free Report)

Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

Recommended Stories

Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.